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this study analyzes the association of excessive energy intake and caloric restriction with breast 
cancer (BC) risk taking into account the individual energy needs of spanish women. We conducted 
a multicenter matched case-control study where 973 pairs completed lifestyle and food frequency 
questionnaires. expected caloric intake was predicted from a linear regression model in controls, 
including calories consumed as dependent variable, basal metabolic rate as an offset and physical 
activity as explanatory. Overeating and caloric restriction were defined taking into account the 99% 
confidence interval of the predicted value. The association with BC risk, overall and by pathologic 
subtype, was evaluated using conditional and multinomial logistic regression models. While 
premenopausal women that consumed few calories (>20% below predicted) had lower BC risk 
(oR = 0.36; 95% CI = 0.21–0.63), postmenopausal women with an excessive intake (≥40% above 
predicted) showed an increased risk (oR = 2.81; 95% CI = 1.65–4.79). For every 20% increase in relative 
(observed/predicted) caloric intake the risk of hormone receptor positive (p-trend < 0.001) and HER2+ 
(p-trend = 0.015) tumours increased 13%, being this figure 7% for triple negative tumours. While high 
energy intake increases BC risk, caloric restriction could be protective. Moderate caloric restriction, in 
combination with regular physical activity, could be a good strategy for BC prevention.
Breast cancer is the most common malignant tumour in women worldwide. Compared to European levels, rates 
in Spain in 2015 are somewhere in the middle, with an age-standardised rate of 88.3 cases1 and 15.7 deaths2 per 
100,000 women-years (based on the European standard).
The role of energy intake on breast cancer risk has been studied in both experimental and observational 
studies. According to the International Agency for Research on Cancer, there is sufficient evidence from exper-
imental animal studies indicating that limiting body-weight gain by caloric restriction has a preventive effect 
on cancer of the mammary gland3. However, the evidence from epidemiological studies is less consistent4–8. 
Suggested biological mechanisms for the beneficial effects of caloric restriction include decreased circulating 
levels of growth factors, anabolic hormones, and cytokines. This in turn leads to a reduction in growth factor sig-
naling, vascular perturbations, and inflammation. Caloric restriction is also involved in lower oxidative stress and 
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free radical-induced DNA damage, better DNA repair processes, improved apoptosis of damaged cells, enhanced 
autophagy and protection from the damaging effects of toxic and genotoxic agents9,10.
On the other hand, high-energy intake has not been consistently associated with increased breast cancer risk 
in human studies11,12. Instead, a positive energy balance, characterized by excessive energy intake (nutritional 
intake) in relation to energy expenditure (physical activity)6, rather than high energy intake per se, may be the 
etiologically relevant factor in breast cancer risk. This positive balance over a prolonged period, results in excess of 
body fat and, consequently, contributes to increased postmenopausal breast cancer risk12,13. Although only a few 
epidemiologic studies have explored the three components of energy balance (energy intake, energy expenditure, 
body mass) simultaneously, all of them detected an increased risk for breast cancer among women with the least 
favorable energy balance profile: high-energy intake, high body mass index (BMI) and low physical activity14–18.
However, beyond physical activity, a more comprehensive measure of energy expenditure is the daily total 
energy expenditure. This measure combines three basic components: basal metabolic rate, energy expenditure 
through physical activity, and the metabolic response to food19. Basal metabolic rate is defined as the energy 
required for maintaining the body’s vital functions under resting conditions, and represents 45 to 70 percent of 
daily total energy expenditure. This rate is determined by the individual’s age, gender, body size, and body com-
position19. It would be very interesting to explore the association between excess or deficit of caloric intake and 
breast cancer risk taking into account the basal metabolic rate of each individual. So, the main aim of this study 
is to investigate the association between relative caloric intake, as a function of daily total energetic expenditure 
and body size, and the risk of breast cancer in Spanish women. Secondary aims include evaluating whether this 
association differs by menopausal status, specific risk profile, and/or tumour pathologic subtype.
Materials and Methods
study population. Between 2006 and 2011, GEICAM, the Spanish Breast Cancer Group (http://www.gei-
cam.org/), recruited 1017 women with histologically confirmed incident breast cancer being treated at 23 hospi-
tals, in 9 Spanish regions. To be eligible for the study participants had to reside in one of the hospitals´ catchment 
area, be between 18–70 years old and be able to complete the epidemiological questionnaire. Each patient (case) 
was matched with a healthy woman (control) usually selected by the patient (friend, neighbor, co-worker…) of a 
similar age (±5 years) and residing in the same city. Patients´ blood-relatives were not eligible.
All procedures performed in studies involving human participants were in accordance with the ethical stand-
ards of the institutional research committees, and with the 1964 Helsinki Declaration and its later amendments 
or comparable ethical standards. The present study was approved by the Clinical Research Ethics Committees 
of the following institutions: Fundación Instituto Valenciano de Oncología; Hospital Universitario Virgen 
del Rocío de Sevilla; Hospital Universitario Puerta del Mar; Hospital Clínico San Carlos de Madrid; Hospital 
Clinic de Barcelona; Hospital Clínico Universitario de Valencia; Fundación Hospital Alcorcón; Complejo 
Hospitalario de Toledo; Hospital Mutua de Terrassa; Hospital Universitari de Bellvitge; Hospital General 
Universitario de Alicante; Hospital Virgen de los Lirios de Alcoy; Hospital Universitari de Girona Dr. Josep 
Trueta; Hospital Mutua de Terrassa; Hospital Universitari Arnau de Vilanova de Lleida; Fundacio d. Osona per a 
la Recerca i Educacio Sanitaries – FORES, and by the Regional Institutional Review Boards of Burgos and Soria, 
Aragon-CEICA, Galicia, Cantabria and Jaen. All participants signed an informed consent and patient informa-
tion was anonymized and de-identified prior to analysis. Further details regarding the study design have been 
previously published20,21.
Data sources and measurements. Both cases and controls completed structured epidemiological ques-
tionnaires assessing demographic and anthropometric characteristics, personal and family background, gynae-
cological, obstetric, medical and occupational history, and lifestyle information (smoking, physical activity, 
and diet). Cases completed the questionnaire within 3 months after diagnosis of breast cancer. When questions 
referred to a specific time period for cases (e.g., the year previous to diagnosis for physical activity or five years 
for dietary habits), the corresponding control was asked about the same calendar period. The questionnaires were 
reviewed by trained interviewers at each center, clarifying any questions participants had. Data entry and quality 
control were performed at the GEICAM headquarters. The accuracy of the information recorded in the database 
was checked by randomly selecting and reviewing 10% of the questionnaires.
Data collected for each participant included age, educational level, height and weight, menopausal status, 
age at menarche, number of children, age at first birth, use of hormone replacement therapy (HRT), previous 
diagnosis of benign breast diseases, family history of breast cancer, physical activity during the year previous 
to diagnosis, smoking status, and diet. Based on highest educational level achieved, participants were classified 
into 3 categories: no formal education - up to first grade; primary education - vocational training; and university 
graduate or higher. BMI was calculated based on participant´s weight one year before the interview and height.
For dietary assessment, cases and controls completed a validated semiquantitative food frequency question-
naire (FFQ) similar to the Harvard questionnaire22. The 117-item FFQ has been adapted to and validated in 
different Spanish adult populations23, and covered eating habits during the preceding 5 years. Patients had nine 
options to describe how frequently they consumed each food item, ranging from “never or less than once per 
month” to “six or more times per day”. Responses were converted to mean daily intake in grams by multiplying 
consumption frequency by the nutrient content of the portion size specified in the FFQ. Finally, total intake of 
each nutrient and total energy intake –in kcals/day- were computed for each participant.
From these data we also calculated level of adherence to the Western, Prudent and Mediterranean dietary pat-
terns. Western dietary pattern (characterized by a high intake of high-fat dairy products, processed meats, refined 
grains, sweets, high-calorie drinks, convenience food, and sauces; and by low intakes of low-fat dairy products 
and whole grain) and Mediterranean dietary pattern (characterized by a high intake of fish, vegetables, legumes, 
boiled potatoes, fruits, olives, and vegetable oil and a low intake of juices) were already associated with breast 
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cancer risk in a previous EpiGeicam study20, and therefore, possible confounders in the present study. These pat-
terns were identified grouping the EpiGEICAM FFQ items, excluding alcoholic beverages, into 26 inter-correlated 
food groups that were log-transformed and centered. Subsequently, Principal Components Analysis without rota-
tion of the variance-covariance matrix was applied. We then calculated the adherence score to Western, Prudent 
and Mediterranean dietary patterns as a linear combination of the weights of each food group (pattern loadings) 
in the previously mentioned study20, and the log-transformed centered food group consumption reported by the 
participants. Adherence scores were classified into quartiles based on controls´ score distribution.
A detailed questionnaire collected a history of physical activity from recreational, occupational, and house-
hold activities, as well as an overall assessment of physical activity considering all these domains using 5 cate-
gories: sedentary (absence of any physical activity, sitting work without physical demand and/or being under 
care), lightly active (mostly household activities of light intensity, occupations without physical exertion, lack 
of recreational activity), moderately active (manual work without handling loads, household activities of higher 
intensity and/or some recreational activity), active (standing or walking occupations, regular recreational physical 
activity), very active (vigorous occupations and/or daily practice of leisure physical activity). Due to the protec-
tive effect of physical activity on breast cancer risk previously detected in these women21, in the present study we 
decided to adjust for overall physical activity during the year previous to the breast cancer diagnosis in cases or 
during the year prior to interview in controls.
statistical analysis. Relative caloric intake was our main variable of interest as a potential predictor of breast 
cancer risk. Its creation consists of several steps detailed below. First, we calculated the basal metabolic rate using 
the predictive equations derived from meta-regression equations of 47 studies developed by Sabounchi et al.24. 
These equations take into account individual´s age, weight, height, gender, and race/ethnicity. An online basal 
metabolic rate prediction tool is also available (http://www.sdl.ise.vt.edu/tutorials.html). Next, we built a linear 
regression model based on data from the control group to estimate the number of calories expected, according 
to women’s basal metabolic rate and physical activity as follows: the amount of calories consumed by women in 
the control group was the dependent variable, the basal metabolic rate was included as an offset in the model 
and physical activity level was included as explanatory variable. From this model, we predicted the expected 
caloric intake per participant, and its 99% confidence interval (expected calories ±2.58 times the standard error). 
Afterwards, we constructed a new variable (relative caloric intake) as follows: The reference category (normal 
caloric intake) included participants whose caloric intake (observed) was within the range defined by the 99% 
confidence interval of their expected caloric intake. Overeating was defined as a relative caloric intake exceeding 
the upper limit (UL) of that interval (observed > UL_expected) and, in turn, undereating was defined as a relative 
caloric intake under the lower limit (LL) of that range interval (observed < LL_expected). Relative intake was sub-
sequently categorized taking into account the percentiles 20 and 80 of the distribution in controls, into 5 catego-
ries: evident undereating (observed/LL_expected intake ≤0.80), moderate undereating (observed/LL_expected 
intake >0.80 with observed intake < LL_expected), normal intake (observed > LL_expected & observed < UL_
expected), moderate overeating (observed/UL_expected intake >1 and ≤1.40) and evident overeating (observed/
UL_expected intake >1.40).
Our primary aim was to evaluate the potential association between relative caloric intake and a diagnosis of 
histologically confirmed invasive breast cancer. Thus, the values for the main outcome variable were Case vs. 
Control. Our secondary aim was similar, but exploring the link between caloric intake and the different patho-
logic breast cancer subtypes. Thus, we created a second dependent variable based on tumour classification accord-
ing to estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 
(HER2) status according to a simplified version of the St Gallen international consensus25. Patients were classified 
as follows: patients with hormone receptor positive (HR+) tumours (ER+ and/or PR+, with HER2-), patients 
with HER2+ tumours (regardless of ER/PR status), or patients with triple negative (TN) tumours (ER-, PR-, and 
HER2-). Controls were the reference category.
Participants’ characteristics were described using counts and percentages for categorical variables and means 
and standard deviations for continuous variables. To check the significance of case-control differences we used 
Pearson Chi-square tests and Student’s t-tests, respectively.
Our primary aim, the potential association between relative caloric intake and breast cancer risk, was assessed 
using conditional logistic regression models. Linear trends were tested by entering the independent variable, 
relative caloric intake, as a continuous term. We adjusted for potential confounders: educational level, BMI one 
year prior to the interview, menopausal status (these last two variables were included in the models with the cor-
responding interaction term), smoking status, age at first birth (with a category of nulliparous), age at menarche, 
history of benign breast disease, family history of breast cancer, HRT use, physical activity, and level of adherence 
to Western and Mediterranean dietary patterns. Additionally, we evaluated the potential effect modification of 
menopause on the predictive variable by including an interaction term between relative caloric intake and men-
opausal status. Finally, the increase in breast cancer risk per every 20% rise in relative caloric intake was also 
assessed by category of other explanatory variables.
Our secondary aim, to test whether the association of interest varied across pathological subtypes, was 
assessed using multinomial logistic regression models with pathological subtype as the dependent variable. 
Models were fully adjusted as described above including also age and recruiting area. Heterogeneity of effects for 
the different cancer subtypes was tested using the Wald statistic.
Finally, given the matching nature of our data, we used Multiple Imputation by Chained Equations to impute 
missing values for overall physical activity during the previous year (8.0%), HRT use (4.9%), age at menarche 
(0.6%), age at first birth (4.7%), smoking (0.3%), weight (2.6%) and height (8.4%). Imputation models included 
these variables as well as the following confounding variables with complete information: case-control status, age, 
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parity, menopausal status, educational level, caloric intake, and previous chronic diseases. Five imputed datasets 
were created using STATA´s multiple imputation procedure.
All statistical analyses were performed by using STATA/MP 14.0 software.
Results
The global participation rate was 82% (75% in cases and 90% in controls). Of the 1017 case-control pairs recruited, 
44 were excluded due to implausible caloric intake values at least in one of each member (below 750 or above 4500 
calories). Thus, the current analyses are based on 973 case-control participant pairs. Compared with controls, 
cases had lower educational level, higher proportion of postmenopausal overweight women, slightly higher age at 
menarche, higher frequency of previous benign breast diseases, more relatives with breast cancer, higher caloric 
intake and more adherence to the Western dietary pattern. The average excess of calories consumed in relation to 
predicted calories (based on their physical activity and their basal metabolic rate) was 296 calories in cases and 
178 calories in controls (Table 1).
Table 2 shows the association between caloric consumption above or below predicted values and breast cancer 
risk, both overall and by menopausal status, including a test for interaction between relative caloric consumption 
and menopausal status. In general, women who consumed substantially fewer calories than their corresponding 
predicted calories (a deficit greater than 20%) had lower breast cancer risk (OR = 0.52; 95% CI = 0.35–0.78). This 
association held only for premenopausal women (p for heterogeneity = 0.001). Women who consumed more 
calories than predicted (up to 40% more) had an increased risk of breast cancer (OR = 1.38; 95% CI = 1.00–1.90), 
However, women who exceeded the predicted intake of calories substantially (40% or more the predicted value) 
had almost twice the risk compared to those whose caloric intake was within the suitable levels (OR = 1.92; 95% 
CI = 1.31–2.82). Such excess risk was concentrated among postmenopausal women (OR = 2.81; 95% CI = 1.65–
4.79) rather than in premenopausal women (p for heterogeneity = 0.001). When we analyzed breast cancer 
risk for every 20% increase in relative caloric intake we observed a positive and statistically significant trend 
(ORper 20% = 1.14; 95% CI = 1.06–1.22). No differences were seen between pre and postmenopausal women 
(p-heterogeneity = 0.734).
Next, we examined the association between caloric intake and breast cancer risk by pathological sub-
type (Table 3). There was a statistically significant positive trend for HR+ and HER2 +tumours, with a 13% 
increased breast cancer risk for every 20% increase in relative caloric consumption. Women reporting substan-
tial caloric deficits (>20% below predicted values) showed a decreased risk of HR+ tumours (OR = 0.60; 95% 
Figure 1. Breast cancer risk for every 20% increase in relative calorie consumption according to women 
characteristics. *Adjusted for menopausal status, educational level, BMI one-year before the interview, smoking 
status, age at first birth, age at menarche, previous benign breast problems, family history of breast cancer, 
hormone replacement therapy use, self-assessed physical activity during the last year, Mediterranean dietary 
pattern and Western dietary pattern.
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Characteristics Cases (n = 973) Controls (n = 973) p value
Age, mean (±SD) 50.4 (±9.6) 50.2 (±9.4) 0.562a
Educational level, n(%)
   No formal education - First grade 208 (22) 160 (16)
   Second grade - Vocational training 510 (52) 491 (51)
   University graduate 255 (26) 322 (33) 0.001a
Age at menarche, mean(±SD) 12.6 (±1.5) 12.4 (±1.5) 0.049b
Age at first birth, mean(±SD) 26.5 (±4.3) 26.2 (±4.3) 0.097b
Number of children, n(%)
   None 215 (22) 220 (23)
   1–2 593 (61) 587 (60)
   3–4 151 (16) 149 (15)
   >4 14 (1) 17 (2) 0.942a
Menopausal status, n(%)
   Premenopausal 551 (57) 513 (53)
   Posmenopausal 422 (43) 460 (47) 0.084a
Body mass index, Kg/m2, mean(±SD)
   Premenopausal 24.4 (±5.9) 24.7 (±5.9) 0.225b
   Posmenopausal 27.3 (±8.1) 26.2 (±6.4) 0.004b
Hormone replacement therapy use, n(%)
   Never 864 (89) 874 (90)
   Ever 109 (11) 99 (10) 0.432b
Previous benign breast problems, n(%)
   No 761 (78) 796 (82)
   Yes 212 (22) 177 (18) 0.047a
Family history of breast cancer, n(%)
   None 728 (75) 782 (80)
   Second degree 129 (13) 105 (11)
   First degree 116 (12) 86 (9) 0.012a
Self-assessed physical activity last year, n(%)
   Sedentary/slightly active 365 (37) 312 (32)
   Moderately active 339 (35) 394 (41)
   Active/very active 269 (28) 267 (27) 0.126b
Smoking status, n(%)
   Never smoker 420 (43) 404 (42)
   Former smoker for ≥6 mo. 258 (27) 254 (26)
Smoker or former smoker for <6 mo. 295 (30) 315 (32) 0.287b
Caloric intake (Kcal/day), mean(±SD) 1990.2 (±615.1) 1897.2 (±628.4) 0.001a
Basal metabolic rate (Kcal/day), mean(±SD) 1316.2 (±137.6) 1309.8 (±122.8) 0.263b
Predicted calories (Kcal/day), mean(±SD) 1694.5 (±305.2) 1718.8 (±291.1) 0.072a
Mediterranean dietary pattern scorec, n(%)
   <5.0812 254 (26) 243 (25)
   5.0812–6.0047 250 (26) 243 (25)
   6.0048–6.8686 263 (27) 244 (25)
   >6.8686 206 (21) 243 (25) 0.250a
Western dietary pattern scorec, n(%)
   <4.104 208 (22) 243 (25)
   4.104–5.150 216 (22) 243 (25)
   5.151–6.197 254 (26) 244 (25)
   >6.197 295 (30) 243 (25) 0.023a
Tumour subtyped, n(%)
   HR+ 653 (67)
   HER2+ 199 (21)
   TN 119 (12)
Table 1. Participant baseline characteristics among breast cancer cases and controls. Abbreviations: 
SD = standard deviation; HR+= hormone receptor positive tumours (ER+ and/or PR + , with HER2−); 
HER2+= human epidermal growth factor receptor 2 positive tumours; TN = triple negative tumours. ap value 
resulting from Pearson Chi-Square test (variables with no missing values). bp value resulting from conditional 
logistic regression models (variables with imputed values). cAccording to the quartiles in the control group. 
dTwo breast cancer cases could not be classified.
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CI = 0.40–0.91), whereas women consuming over 40% of predicted calories had a higher risk of HR+ (OR = 1.82; 
95% CI = 1.22–2.70) and HER2+ (OR = 2.05; 95% CI = 1.11–3.76) tumours. A similar trend was observed for 
TN tumours, although the associations failed to attain statistical significance probably due to the limited number 
of cases.
Figure 1 depicts the breast cancer risk for every 20% increase in relative caloric consumption per category 
of the other explanatory variables. The effect was very consistent across all strata. However, it is worth noting 
the particularly increased risk observed in women with low adherence to the Mediterranean dietary pattern 
(OR = 1.32; 95% CI = 1.15–1.51; p-heterogeneity = 0.056), as well as in nulliparous women (OR = 1.27; 95% 
CI = 1.11–1.44; p-heterogeneity = 0.075).
Discussion
The present study analyzes the association between breast cancer risk and women’s relative caloric intake (actual/
predicted intake) according to participants’ physical activity and basal metabolic rate. Our results suggest that 
restricted caloric intake offers a protective effect against breast cancer, especially in premenopausal women, 
whereas excessive caloric consumption increases breast cancer risk. The latter effect is observed mainly among 
postmenopausal women and women reporting low adherence to the Mediterranean diet. A positive association 
between relative caloric intake and breast cancer was observed in all pathologic subtypes, though the association 
failed to reach statistical significance among women with TN tumours due, most likely, to a limited number of 
cases.
This study has several strengths. First, this is a multicenter study carried out in 9 Spanish regions located 
throughout the second largest country in Europe. Second, to our knowledge, this is the first epidemiological 
study to date that explores the effect of caloric deficit or excessive caloric consumption according to the individual 
energy requirements of each woman based on her basal metabolic rate and physical activity performed. Previous 
studies have examined the joint effect of energy intake, physical activity, and body size; however, their analyses 
were stratified by those three components14–18. Third, because physiological pathways and metabolic effects of 
calories vary by source (i.e., calories from proteins, fats, carbohydrates…) we adjusted our models for quartile lev-
els of adherence to the Mediterranean and Western dietary patterns, both associated with breast cancer risk and 
previously identified among our participants20. All the possible combinations of these two variables allowed us to 
capture (and adjust for) the broad diversity of food consumption patterns found across Spain. Fourth, regarding 
breast cancer subtypes, as far as we are aware of, this is the first study exploring the association between caloric 
intake and breast cancer risk considering HER2 status separately. Finally, the large sample of premenopausal par-
ticipants allowed for a fully adjusted exploration of the effect of caloric consumption on this group.
Several limitations should be considered when interpreting our findings. First, the explanatory variables of 
interest are based on self-reported data, thus subject to recall bias. In particular, even though the FFQ used 
showed a satisfactory validity and reproducibility23, there is evidence that overweight or obese individuals tend to 
underestimate their weight and caloric intake and to overestimate their physical activity26. To minimize this bias, 
we performed sensitivity analyses to test whether the effect of caloric intake was consistent across four categories 
of BMI (<20, 20–25, 25–30 and >30 Kg/m2). The resulting associations were very similar to those reported here, 
with no evidence of heterogeneity (data not shown). Therefore, we believe that this potential bias, is very likely 
non-differential, and thus, our reported associations would, in any case, underestimate the real ones. Further, 
although we collected very detailed information on recreational physical activity21 we forewent this information 
in favor of categories of overall physical activity to estimate the expected caloric consumption. We made this deci-
sion because leisure physical activity does not realistically capture the amount of exercise performed by women in 
this context, especially in the case of less educated women27. However, when sensitivity analyses were performed 
with the subgroup of women with complete information on metabolic equivalents (MET-h/week) from leisure 
physical activities, the results were no different from those reported here (data not shown). On the other hand, 
All women (n = 1946) Premenopausal women (n = 1064) Postmenopausal women (n = 882)
p-het
controls cases
ORa (95% CI) p value
controls cases
ORa (95% CI) p value
controls cases
ORa (95% CI) p value(n = 973) (n = 973) (n = 513) (n = 551) (n = 460) (n = 422)
Relative caloric intake
  More than 20% below predicted calories 162 105 0.52 (0.35–0.78) 0.001 92 51 0.36 (0.21–0.63) <0.001 70 54 0.77 (0.44–1.35) 0.365 0.001
  Up to 20% below predicted calories 180 165 0.93 (0.66–1.31) 0.685 100 97 0.77 (0.49–1.24) 0.283 80 68 1.14 (0.68–1.92) 0.624 0.503
  Within range of predicted calories (ref) 152 136 1.00 64 77 1.00 88 59 1.00
  Up to 40% above predicted calories 301 330 1.38 (1.00–1.90) 0.048 156 195 1.16 (0.75–1.81) 0.498 145 135 1.55 (0.98–2.47) 0.062 0.144
  More than 40% above predicted calories 178 237 1.92 (1.31–2.82) 0.001 101 131 1.40 (0.85–2.31) 0.182 77 106 2.81 (1.65–4.79) <0.001 0.001
  Trend per 20% increase over the predicted range 1.14 (1.06–1.22) <0.001 1.13 (1.04–1.22) 0.003 1.15 (1.05–1.25) 0.002 0.734
Table 2. Multivariate analysis of caloric intake above or below predicted calories and breast cancer risk by 
menopausal status. Abbreviations: OR = odds ratio; CI = confidence interval; p = p value; p-het = p value for 
heterogeneity. aAdjusted for educational level, body mass index one-year before the interview, smoking status, 
age at menarche, age at first birth (with a category of nulliparous), previous benign breast problems, family 
history of breast cancer, hormone therapy use, recent physical activity, level of adherence to Mediterranean and 
Western dietary patterns, and menopausal status (all women). Adjusted for age and hospital by design.
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the fact of having selected friends, partners or not blood-relatives as controls of breast cancer cases could entail 
a greater similarity in lifestyles, including dietary habits among cases and controls. However, if this bias exists, 
it would imply an underestimation of the effects studied, and so, the associations reported here would underes-
timate the real ones. Being a case-control study, another limitation to take into account is that all information 
(dietary habits, physical activity, etc) in cases was collected after diagnosis. This may have caused differential recall 
between cases and controls that could have skewed the results. However, this differential bias could be minimized 
because women were not aware of the specific hypothesis we investigated and we used a well-structured and 
validated instrument for dietary assessment with a wide temporal window (5 years prior to the diagnosis of the 
corresponding case) thus expecting similar misclassification errors in cases and controls. Regarding pathologic 
subtypes, we had an insufficient number of cases with TN tumours to achieve statistical power to test heterogene-
ity, since TN tumours are relatively uncommon in our patient population28. Finally, even though most established 
risk factors were taken into account, residual confounding cannot be ruled out.
Our results show that women who consumed fewer than 80% of the calories expected based on their phys-
ical activity and basal metabolic rate, had lower breast cancer risk. There is sufficient evidence based on ani-
mal models that limiting body weight gain by caloric restriction prevents cancer of the mammary gland3. Some 
observational epidemiological studies provide additional evidence that caloric restriction provides humans cer-
tain protection against cancer4,8,9. In fact, recent clinical intervention trials have demonstrated that some met-
abolic and molecular adaptations observed in experimental animals also take place in humans in response to 
caloric restriction29. Short-term studies with overweight and obese subjects have shown that caloric restriction 
may reduce circulating concentrations of inflammatory markers such as C-reactive protein, tumour necrosis 
factor-α and interleukin-6, improve insulin sensitivity, increase serum concentrations of insulin-like growth fac-
tor binding protein (IGFBP)-1 and IGFBP-2, increase circulating levels of adiponectin, and reduce leptin and the 
leptin-to-adiponectin ratio9,30. In addition, caloric restriction affects multiple processes involved in the pathogen-
esis of cancer including a reduction of oxidative stress and free radical-induced DNA damage, an enhancement of 
DNA repair processes, an increase in removal of damaged cells through apoptosis, an enhancement in autophagy 
and protection from the damaging effects of toxic agents9,10.
The protective effect of caloric restriction has been observed in both our premenopausal and postmenopausal 
participants. Previous observational studies have shown that weight loss through caloric restriction reduces the 
risk of postmenopausal breast cancer4,30. In premenopausal participants of a randomized trial, Harvie and col-
leagues observed that both intermittent and continuous caloric restriction during 6 months resulted in weight 
loss in 107 overweight or obese women together with improvements in several cancer risk markers31. Among the 
metabolic effects of this voluntary weight loss, several studies have demonstrated a substantial reduction in bio-
markers of estrogen stimulation and inflammation, among both premenopausal and postmenopausal women32. 
However, we observed that postmenopausal women in our study had to consume substantially fewer calories 
than predicted to reduce their breast cancer risk. Thus, we conclude that postmenopausal women would need a 
stricter hypocaloric diet to reduce their body fat and, hence, their estrogen exposure through aromatization of 
adrenal androgens.
Although most case-control and prospective studies have found a positive association between high energy 
intake and breast cancer risk, others have not11,12. Excessive caloric intake results in weight gain and body fatness 
which, in turns, is strongly associated with postmenopausal breast cancer risk. However, greater body fatness before 
the menopause seems to protect against premenopausal breast cancer12,13. To take into account the possible differ-
ential effect of obesity in pre and postmenopausal women, all models were adjusted by the interaction term between 
both variables. Nevertheless, in our study, the association between obesity and breast cancer was not significant 
among premenopausal women (OR = 0.98, IC(95%) = 0.95–1.02). Interestingly, although breast cancer risk asso-
ciated with excessive caloric intake was significantly higher among postmenopausal women, the risk for every 20% 
increase in relative caloric consumption was practically the same in both groups. It should be borne in mind that 
controls HR + (n = 653) HER2 + (n = 199) TN (n = 119)
p-het(n = 971) cases ORb (95% CI) p value cases ORb (95% CI) p value cases ORb (95% CI) p value
Relative caloric intake
  More than 20% below predicted calories 162 69 0.60 (0.40–0.91) 0.015 21 0.60 (0.31–1.14) 0.119 15 0.55 (0.25–1.22) 0.142 0.980
  Up to 20% below predicted calories 180 110 1.03 (0.72–1.48) 0.862 38 1.27 (0.73–2.19) 0.398 16 0.85 (0.40–1.78) 0.658 0.631
  Within range of predicted calories (ref) 152 92 1.00 28 1.00 16 1.00
  Up to 40% above predicted calories 299 218 1.34 (0.96–1.88) 0.083 65 1.44 (0.86–2.42) 0.164 46 1.69 (0.89–3.22) 0.109 0.782
  More than 40% above predicted calories 178 164 1.82 (1.22–2.70) 0.003 47 2.05 (1.11–3.76) 0.021 26 1.89 (0.88–4.07) 0.102 0.933
  Trend per 20% increase over the predicted range 1.13 (1.06–1.21) <0.001 1.13 (1.03–1.25) 0.015 1.07 (0.94–1.21) 0.318 0.670
Table 3. Multivariate logistic analysis of relative caloric intake and breast cancer risk by pathological subtypea. 
Abbreviations: HR+= hormone receptor positive tumours (ER+ and/or PR+, with HER2-); HER2+= 
human epidermal growth factor receptor 2 positive tumours; TN = triple negative tumours; OR = odds ratio; 
CI = confidence interval; p = p value; p-het = p value for heterogeneity. aTwo breast cancer cases could not be 
classified. bAdjusted for age, hospital, educational level, body mass index one-year before the interview, smoking 
status, age at menarche, age at first birth (with a category of nulliparous), menopausal status, previous benign 
breast problems, family history of breast cancer, hormone therapy use, recent physical activity, and level of 
adherence to Mediterranean and Western dietary patterns.
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body fatness is the result of maintained energy disbalance in the past, and from that perspective, overeating in pre-
menopausal women will translate into higher BMI in the future, possibly after menopause. Taking this consideration 
into account, our results do not contradict, but are in agreement with what is already known based on BMI. From a 
public health point of view, they emphasize the importance of reducing excessive caloric intake before menopause. 
On the other hand, because total caloric intake is highly related to body size and physical activity, it is difficult 
to assess the independent effect of caloric intake on breast cancer risk. Two previous cohort studies found that 
women with the most unfavorable balance profile (i.e., high energy intake, high BMI, and low physical activity) had 
increased premenopausal17 and postmenopausal14 breast cancer risk. Results further confirmed by two case-control 
studies16,18. Whereas Mallin and co-authors observed that the profile characterized by high energy intake and low 
physical activity was associated with a higher breast cancer risk among postmenopausal women16, Zhang and col-
leagues found a 60%-70% increased risk associated with high energy intake only among premenopausal women18.
In our study, relative caloric intake seemed to have a similar effect on the risk of all pathologic subtypes 
of breast cancer, suggesting that there must be biological mechanisms, other than those related to the hormo-
nal pathway, influencing this association. Zhang et al., in a case control study of women enrolled in the Breast 
Cancer Family Registry, found that the association between high energy intake and breast cancer risk was only 
significant in women with HR+ tumours18. In addition, some experimental studies with mice have shown that 
caloric restriction may reduce the risk of HER2+ breast cancer33, decreases metastatic burden in TN breast cancer 
patients34, or slow tumour growth regardless of tumour subtype35.
The breast cancer risk associated with excessive caloric consumption was higher in women with low adherence 
to the Mediterranean dietary pattern. This result is in line with the qualitative approach by Lucan and colleagues36. 
According to this approach, what contributes to obesity and related diseases is not the number of calories in specific 
foods but rather the amount and type of carbohydrates these foods contain. Foods that are highly processed, and mostly 
comprised of rapidly absorbable sugars and starches, may be of greatest concern. Such carbohydrates, not typical of the 
Mediterranean diet, may induce neurohormonal alterations that lead to “eating more” and “moving less”36. In contrast, 
Bray et al.37 found that, given equal numbers of extra calories, weight gain was lower with a low protein diet compared 
with a normal protein diet. Whereas calories alone contributed to body fat increase, protein intake contributed to 
changes in energy expenditure and storage of lean body mass, but not to an increase in body fat37.
In summary, we found that women with a high relative caloric intake, i.e., above the expected intake according 
to physical activity and body size, presented increased breast cancer risk, with caloric restriction showing a pro-
tective effect. This association was observed in both premenopausal and postmenopausal women and across all 
pathologic breast cancer subtypes. Given that the prevalence of sedentarism is increasing in Spain (44% reported 
never exercised or played sports in the 2013 Eurobarometer Survey)38, that the prevalence of overweight and 
obese women has also increased progressively (54.6% in 2014)39, and that the consumption and variety of fast 
food has spread widely in recent years in Spanish households40, individual and public health strategies should be 
implemented especially in high-risk women. Moderate caloric restriction in combination with regular physical 
activity could have beneficial effects on health. Future prospective studies are needed to confirm these results in 
other populations and to elucidate the mechanisms underlying them.
Data Availability
The datasets on which the present analyses are based are not publicly available, owing to incompatibility with the 
regulations of the different ethics committees in the contributing study centers. However, these datasets may be 
available from GEICAM upon request, provided that all committees accept it.
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